Evidence map›Paper›PMID 41869937›Full record

ArticleMolecular imaging and radionuclide therapy2026

Multimodal Functional Imaging in Tumor-induced Osteomalacia:

Zehranur Tosunoğlu, Utku Erdem Soyaltın, İpek Öztürk, Meryem Kaya, Burcu Esen Akkaş, Esra Arslan

Abstract read
In one paragraph

Article in Molecular imaging and radionuclide therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zehranur TosunoğluUniversity of Health Sciences Türkiye, İstanbul Training and Research Hospital, Clinic of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0002-8509-1583
Utku Erdem SoyaltınEge University Faculty of Medicine, Department of Internal Medicine, Division of Endocrinology and Metabolism, İzmir, Türkiye.ORCID 0000-0003-0229-3452
İpek ÖztürkUniversity of Health Sciences Türkiye, Başakşehir Çam and Sakura City Hospital, Clinic of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0003-4183-5824
Meryem KayaUniversity of Health Sciences Türkiye, Başakşehir Çam and Sakura City Hospital, Clinic of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0002-3328-8173
Burcu Esen AkkaşUniversity of Health Sciences Türkiye, Başakşehir Çam and Sakura City Hospital, Clinic of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0001-6623-1600
Esra ArslanUniversity of Health Sciences Türkiye, İstanbul Training and Research Hospital, Clinic of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0002-9222-8883

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor-induced osteomalacia, resulting from tumoral overproduction of fibroblast growth factor 23, is a rare paraneoplastic syndrome clinically characterized by muscle weakness, bone pain, and pathological fractures. Fewer than 1,000 cases have been reported in the literature. Laboratory findings typically include hypophosphatemia, normal or decreased levels of 1.25-dihydroxy vitamin D, and normal or elevated levels of FGF23. Functional imaging methods, particularly somatostatin receptor imaging, play an important role in the localization of the tumor. In this case of tumor-induced osteomalacia, we presented the findings from gallium-68 (

Indexed as

18F-FDG PET/CT68Ga-DOTATATE PET/CT68Ga-FAPI PET/CTphosphaturic mesenchymal tumorsTumor-induced osteomalacia

Identifiers

PMID41869937
PMCPMC13640840

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.